Home
Rhodes Pharmaceuticals

Rhodes Pharmaceuticals Market Share Analysis for June 2026

Industry: N/A

Domainrhodespharma.com

Year Founded2008

Employees51 - 200

Annual Revenue$15M - $25M

Rhodes Pharmaceuticals

Rhodes Pharmaceuticals (including company regionals)

rhodespharma.com

See more website traffic and engagement information

Rhodes Pharmaceuticals Revenue up to June 2026 is 15M - 25M

revenue generated by Rhodes Pharmaceuticals top domains

Rhodes Pharmaceuticals top domains revenue over 3 years

Revenue for Rhodes Pharmaceuticals top domains

rhodespharma.com15M - 25M

See more with Sales Intelligence

Total visits to Rhodes Pharmaceuticals's top domains

Understand Rhodes Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

rhodespharma.com3.9K

See more with Sales Intelligence

Avg. visit duration in Rhodes Pharmaceuticals's top domains

Analyze Rhodes Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

rhodespharma.com00:01:40

See more with Sales Intelligence

Avg. pageviews on Rhodes Pharmaceuticals's top domains

See how Rhodes Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

rhodespharma.com3.81

See more with Sales Intelligence

Rhodes Pharmaceuticals top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Rhodes Pharmaceuticals

These are the website technologies, by industry, used by Rhodes Pharmaceuticals top domains

Conversion & Analytics (3)

Google Analytics

Email Services (2)

Microsoft Exchange Online

Mobile (2)

Meta Viewport

Recruitment (2)

SAP SuccessFactors

More Technologies

7

See all

News & Signals from Rhodes Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRhodespharma launched authorized generic version of Aptensio XR CII 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg and 60 mg capsules on May 4th '20.Rhodes Pharmaceuticals L.P. today announced the launch of an authorized generic version of Aptensio XR® (methylphenidate hydrochloride extended-release) CII 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg and 60 mg capsules in the United States.

NewsRhodespharma filed suit against Indivior PLC on Jan 1st '16.In 2016, for example, Rhodes Pharmaceuticals filed a lawsuit against Indivior alleging patent infringement.